
Sign up to save your podcasts
Or


In part 2 Prof. Nicolas Mottet discusses which are the most important changes in the new EAU Guidelines for Prostate Cancer treatment related to genetic testing, M1 disease and Castration-resistant prostate cancer (CRPC).
Listen also to part 1 about perineal biopsy, staging PSMA, adjuvant Radio Therapy.
By European Association of Urology3.7
33 ratings
In part 2 Prof. Nicolas Mottet discusses which are the most important changes in the new EAU Guidelines for Prostate Cancer treatment related to genetic testing, M1 disease and Castration-resistant prostate cancer (CRPC).
Listen also to part 1 about perineal biopsy, staging PSMA, adjuvant Radio Therapy.

321 Listeners

504 Listeners

59 Listeners

38 Listeners

99 Listeners

80 Listeners

284 Listeners

36 Listeners

59 Listeners

2 Listeners

89 Listeners

57 Listeners

12 Listeners

0 Listeners

18 Listeners